VOORHEES, N.J., July 1 Clostridium difficile infection(CDI) is a serious condition that causes disease with a wide spectrum ofseverity, ranging from mild diarrhea to pseudomembranous colitis and death.Recurrent CDI can occur in up to 20% of patients who develop an initial caseof CDI.(1) These patients are at increased risk of additional recurrences, aswell as more complicated disease, including toxic megacolon, colonperforation, and systemic inflammatory response syndrome with organ failureleading to colectomy or death.
To address the need for education on recurrent CDI, Robert MichaelEducational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM)are jointly sponsoring a 3-part series of complimentary educationalnewsletters targeted to primary care physicians. Current Concepts inClostridium difficile Infection: A Focus on Recurrent Disease is the firstnewsletter of this series.
The Expert Faculty for this continuing education activity include CiaranP. Kelly, MD, Associate Professor of Medicine at Harvard Medical School,Director of Gastroenterology Fellowship Training at Beth Israel DeaconessMedical Center, and Chief of Hermann L. Blumgart Internal Medicine, and VivianG. Loo, MD, MSc, FRCPC, Chief of the Department of Microbiology at McGillUniversity Health Centre.
Healthcare professionals can receive this self-study activity bydownloading or ordering online at http://www.rmei.com/CDInewsletters.
Healthcare professionals who treat patients with CDI should take advantageof this opportunity to learn about the management of patients with recurrentCDI.
This continuing education opportunity is jointly sponsored by RobertMichael Educational Institute LLC and Postgraduate Institute for Medicine andis supported by an educational grant from ViroPharma Incorporated.
Robert Michael Educational Institute LLC is a full-service medicaleducation company dedicated to providing comprehensive medical education tohealthcare providers, patients, and caregivers. Our mission is to designprograms that improve diagnosis and treatment through a variety of educationalprogramming such as national and international symposia, teleconferences, livemeetings, enduring print materials, and interactive Internet programs.
For other educational opportunities, please visit www.RMEI.com.
(1) McFarland LV, Surawicz CM, Rubin M, et al. Recurrent Clostridiumdifficile disease: epidemiology and clinical characteristics. Infect ControlHosp Epidemiol. 1999;20:43-50.
SOURCE Robert Michael Educational Institute LLC